Showing results (11-20 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|January 31, 2022
Defining routine fatigue care in Multiple Sclerosis in the United Kingdom: What treatments are offered and who gets them?Federica Picariello, Jennifer Freeman, Rona Moss-Morris
Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 11, 2022
Perspectives and experiences with COVID-19 vaccines in people with MSJohn R Ciotti, Dana C Perantie, Brandon P Moss, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 26, 2019
Exploratory MRI measures after intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosisJenny Feng, Erik Offerman, Jian Lin, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 11, 2018
Cerebrospinal fluid GAP-43 in early multiple sclerosisU Rot, Å Sandelius, A Emeršič, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 2, 2021
Research interrupted: The impact of the COVID-19 pandemic on multiple sclerosis research in the field of rehabilitation and quality of lifeRebecca Maguire, Sinead Hynes, Barbara Seebacher, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 2, 2021
The impact of cognitive rehabilitation on quality of life in multiple sclerosis: A pilot studyKathleen C Munger, Amy Pacos Martinez, Megan H Hyland
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 15, 2020
Evaluation of the 'ring sign' and the 'core sign' as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosisNelly Blindenbacher, Eveline Brunner, Susanna Asseyer, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 21, 2021
AQP4-IgG autoimmunity in Japan and Germany: Differences in clinical profiles and prognosis in seropositive neuromyelitis optica spectrum disordersSusanna Asseyer, Hiroki Masuda, Masahiro Mori, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 4, 2021
Treatment-emergent adverse events occurring early in the treatment course of cladribine tablets in two phase 3 trials in multiple sclerosisJiwon Oh, Bryan Walker, Gavin Giovannoni, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 9, 2019
Efficacy of dimethyl fumarate in Japanese multiple sclerosis patients: interim analysis of randomized, double-blind APEX study and its open-label extensionT Kondo, I Kawachi, Y Onizuka, et al.
Pageof 61